Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) Research & Development (2016 - 2025)

Milestone Scientific's Research & Development history spans 16 years, with the latest figure at $16226.0 for Q3 2025.

  • For Q3 2025, Research & Development fell 93.01% year-over-year to $16226.0; the TTM value through Sep 2025 reached $654667.0, down 19.98%, while the annual FY2024 figure was $858767.0, 22.44% up from the prior year.
  • Research & Development for Q3 2025 was $16226.0 at Milestone Scientific, down from $51789.0 in the prior quarter.
  • Across five years, Research & Development topped out at $464466.0 in Q1 2022 and bottomed at $16226.0 in Q3 2025.
  • The 5-year median for Research & Development is $215420.0 (2021), against an average of $211878.8.
  • The largest annual shift saw Research & Development soared 2724.53% in 2022 before it tumbled 93.01% in 2025.
  • A 5-year view of Research & Development shows it stood at $290167.0 in 2021, then fell by 12.81% to $252991.0 in 2022, then tumbled by 30.07% to $176906.0 in 2023, then increased by 22.96% to $217532.0 in 2024, then tumbled by 92.54% to $16226.0 in 2025.
  • Per Business Quant, the three most recent readings for MLSS's Research & Development are $16226.0 (Q3 2025), $51789.0 (Q2 2025), and $369120.0 (Q1 2025).